A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia
| Autor: | Levis, Mark, Perl, Alexander, Schiller, Gary, Fathi, Amir T., Roboz, Gail, Wang, Eunice S., Altman, Jessica, Rajkhowa, Trivikram, Ando, Makoto, Suzuki, Takeaki, Subach, Ruth Ann, Maier, Gary, Madden, Timothy, Johansen, Mary, Cheung, Kin, Kurman, Michael, Smith, Catherine |
|---|---|
| Zdroj: | In Blood Advances 28 May 2024 8(10):2527-2535 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|